A new era in atherosclerosis drug discovery.
作者信息
Meng Charles Q
出版信息
Expert Rev Cardiovasc Ther. 2004 Sep;2(5):633-6. doi: 10.1586/14779072.2.5.633.
PMID:15350164
Abstract
摘要
相似文献
1
A new era in atherosclerosis drug discovery.
Expert Rev Cardiovasc Ther. 2004 Sep;2(5):633-6. doi: 10.1586/14779072.2.5.633.
2
[Modification of lipoprotein metabolism. A new era].
Rev Clin Esp. 1990 Mar;186(4):149-50.
3
[Ezetimib].
Dtsch Med Wochenschr. 2004 Sep 24;129(39):2038-40. doi: 10.1055/s-2004-831843.
4
In search of an endpoint.
Curr Opin Lipidol. 2000 Oct;11(5):447-50. doi: 10.1097/00041433-200010000-00001.
5
[Hypocholestermic agents in therapy].
Clin Ter. 1966 Oct 15;39(1):65-77.
6
[Synthesis plus absorption inhibitors are useful for high risk patients].
Med Monatsschr Pharm. 2007 Mar;30(3):118-9.
7
Aortic sclerosis, aortic stenosis and lipid-lowering therapy.
Expert Rev Cardiovasc Ther. 2008 Mar;6(3):385-90. doi: 10.1586/14779072.6.3.385.
8
Fluvastatin and fluvastatin extended release: a clinical and safety profile.
Expert Rev Cardiovasc Ther. 2004 Sep;2(5):641-52. doi: 10.1586/14779072.2.5.641.
9
Atherosclerosis--an inflammatory disease.
N Engl J Med. 1999 Jun 17;340(24):1928; author reply 1929.
10
Statins: an effective anti-atherosclerosis therapy.
Isr Med Assoc J. 2002 Jun;4(6):456-7.
Zotero 插件